Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco “Whistleblowers” Include Ex-Employees, False Claims Professional

Executive Summary

The Medco "whistleblower" cases indicate the extent to which participants in the pharmaceutical sector are vulnerable to False Claims Act cases
Advertisement

Related Content

Medco/Oxford Services Contract Is Basis Of “Kickback” Allegation In DoJ Suit
Medco/Oxford Services Contract Is Basis Of “Kickback” Allegation In DoJ Suit
Medco Puts Number On DoJ Case: Settlement Should Be Less Than $42.5 Mil.
Compliance Officers Make Good “Whistleblowers” – U.S. Prosecutor Sheehan
“Whistleblower” Cases Reflect Evidence, Not Personality, Prosecutor Says
Merck, Lilly, J&J Pricing Practices Praised By AWP "Whistleblower"
Medco, PCS Among Firms Subpoenaed In Philadelphia PBM Investigation
Reproductive Toxicity Factors Weighted Equally To Guard Against Bias - FDA
Reproductive Toxicity Factors Weighted Equally To Guard Against Bias - FDA
PBM/Manufacturer Deals May Skirt Medicaid Rebate Law - Prosecutor
Advertisement
UsernamePublicRestriction

Register

PS042052

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel